TweetRecent medical advances suggest that cures may be possible for infections hemorrhagic fevers caused by filovirues, including the potential bioweapon Ebola and Marburg viruses. The infections are currently considered incurable, and no treatment candidates have been tested in the field. … Read More

TweetAVI BioPharma, Inc., recently received approval from the U.S. Food and Drug Administration for post-exposure prophylaxis studies on a vaccine targeting Marburg virus infection. The FDA approved AVI BioPharma to begin safety and efficacy studies of the single oligomer vaccine, … Read More

Agenus, Inc., has announced a licensing agreement with Integrated BioTherapeutics, Inc., to use the QS-21 Stimulon Read More

Paragon Bioservices announced this week that it has been awarded $4.99 million dollars by the U.S. Army to assist the USAMRIID in developing vaccines against such diseases as Ebola Sudan, Ebola Zaire and Marburg virus. Read More

Officials with the U.S. Army Medical Research Institute of Infectious Diseases and AVI BioPharma announced that they have created a drug that showed effectiveness in combating the Marburg and Ebola viruses. Read More